Stay updated with breaking news from Next Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Craig Hallum initiated coverage on shares of Guardant Health (NASDAQ:GH – Free Report) in a research note issued to investors on Wednesday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $28.00 target price on the stock. GH has been the subject of several other reports. Canaccord Genuity Group cut their price objective […]
Craig Hallum assumed coverage on shares of Guardant Health (NASDAQ:GH – Free Report) in a research report sent to investors on Wednesday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $28.00 price objective on the stock. A number of other research analysts have also weighed in on the company. Guggenheim reissued a […]
Craig Hallum began coverage on shares of Guardant Health (NASDAQ:GH – Free Report) in a research report sent to investors on Wednesday, Marketbeat.com reports. The firm issued a buy rating and a $28.00 price target on the stock. Several other brokerages have also issued reports on GH. The Goldman Sachs Group decreased their target price […]
Guardant Health (NASDAQ:GH – Free Report) had its target price cut by The Goldman Sachs Group from $32.00 to $28.00 in a research report released on Monday morning, Benzinga reports. They currently have a buy rating on the stock. Other equities analysts have also recently issued research reports about the company. JPMorgan Chase & Co. […]
Guardant Health (NASDAQ:GH – Get Free Report)‘s stock had its “neutral” rating reiterated by investment analysts at Guggenheim in a research report issued on Friday, Benzinga reports. Several other equities research analysts have also recently issued reports on the stock. Wolfe Research initiated coverage on shares of Guardant Health in a research report on Wednesday, […]